Advertisement
Advertisement
COCH
Envoy Medical, Inc. Class A Common Stock
0.48
USDSponsored
-0.05
-9.43%
Feb 06, 15:59 UTC -5
Closed
After-Market
0.47
-0.01
-2.50%
COCH Earnings Reports
Positive Surprise Ratio
COCH beat 1 of 8 last estimates.
13%
Next Report
Date of Next Report
Mar 31, 2026
Estimate for Q4 25 (Revenue/ EPS)
$56.10K
/-$0.32
Implied change from Q3 25 (Revenue/ EPS)
+33.57%
/-5.88%
Implied change from Q4 24 (Revenue/ EPS)
+33.57%
/-30.43%
Envoy Medical, Inc. Class A Common Stock earnings per share and revenue
On Nov 10, 2025, COCH reported earnings of -0.34 USD per share (EPS) for Q3 25, missing the estimate of -0.31 USD, resulting in a -7.53% surprise. Revenue reached 42.00 thousand, compared to an expected 71.40 thousand, with a -41.18% difference. The market reacted with a -0.34% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.32 USD, with revenue projected to reach 56.10 thousand USD, implying an decrease of -5.88% EPS, and increase of 33.57% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
FAQ
What were Envoy Medical, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Envoy Medical, Inc. Class A Common Stock reported EPS of -$0.34, missing estimates by -7.53%, and revenue of $42.00K, -41.18% below expectations.
How did the market react to Envoy Medical, Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved down -0.34%, changed from $0.70 before the earnings release to $0.70 the day after.
When is Envoy Medical, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Mar 31, 2026.
What are the forecasts for Envoy Medical, Inc. Class A Common Stock's next earnings report?
Based on 4
analysts, Envoy Medical, Inc. Class A Common Stock is expected to report EPS of -$0.32 and revenue of $56.10K for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement